China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 32,900 shares, a drop of 54.8% from the February 28th total of 72,800 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average trading volume of 127,900 shares, the days-to-cover ratio is currently 0.3 days.

China SXT Pharmaceuticals Stock Up 1.1 %

SXTC opened at $2.75 on Friday. The firm’s 50-day simple moving average is $3.43 and its 200-day simple moving average is $3.86. China SXT Pharmaceuticals has a twelve month low of $2.40 and a twelve month high of $26.96.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read More

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.